Relationship between long-acting reversible contraception and acne in a cohort of adolescents and young adults

被引:1
|
作者
Boos, Markus D. [1 ,2 ,8 ]
Ryan, Morgan E. [3 ]
Milliren, Carly [3 ]
Golub, Sarah [4 ]
Maslyanskaya, Sofya [5 ]
Escovedo, Michelle [6 ]
Divasta, Amy [7 ]
Pitts, Sarah [7 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Dermatol, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[4] Univ Washington, Seattle Childrens Hosp, Sch Med, Dept Pediat, Seattle, WA USA
[5] Childrens Hosp Montefiore, Div Adolescent Med, New York, NY USA
[6] Childrens Hosp Los Angeles, Div Adolescent Young Adult Med, Los Angeles, CA USA
[7] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA
[8] Seattle Childrens Hosp, Dept Surg, 4800 Sand Point Way NE,OC9 833, Seattle, WA 98105 USA
关键词
acne; adolescence; long-acting reversible contraception; progestin;
D O I
10.1111/pde.15578
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of progestin-only long-acting reversible contraception (LARC) may be a risk factor for acne. Few studies have focused primarily on the effects of hormonal LARC on the development or exacerbation of acne in adolescents and young adults. We sought to understand the incidence and management of acne following hormonal LARC insertion in this adolescent/young adult population.MethodsA secondary data analysis was conducted of prospectively collected quality improvement (QI) data from the Adolescent Medicine LARC Collaborative. Subjects were evaluated by clinicians in adolescent medicine clinics at participating study sites, and acne severity was documented using a standardized recording instrument and scale. Descriptive statistics were reported as frequencies and percentages for categorical variables or mean and standard deviation (SD) for continuous variables. We compared demographic and clinical characteristics by those who had worsening acne, accounting for site inter-correlation using Cochran-Mantel-Haenszel chi-square tests for categorical variables and linear generalized estimating equation (GEE) regression for continuous variables.ResultsOf 1319 subjects who completed LARC insertion, 28.5% (376/1319) experienced worsening acne following use of progestin-only LARC. Acne was a contributing factor to LARC removal in only 3% (40/1319), and the sole reason for removal in 0.4% (5/1319) of all subjects. As this was a secondary analysis of prospectively collected QI data, limitations of this study include incomplete or inaccurate documentation of acne severity. Moreover, LARC insertions without follow-up/removal visits or with only follow-up/removal within 8 weeks of insertion were excluded from our study, which may also bias results.ConclusionsAdolescents and young adults seeking progestin-only LARC should be counseled about the potential for developing acne or experiencing a worsening of existing acne during LARC use. However, acne was not a common reason for LARC discontinuation.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [21] Trends in Long-Acting Reversible Contraception Use in Adolescents and Young Adults: New Estimates Accounting for Sexual Experience
    Pazol, Karen
    Daniels, Kimberly
    Romero, Lisa
    Warner, Lee
    Barfield, Wanda
    JOURNAL OF ADOLESCENT HEALTH, 2016, 59 (04) : 438 - 442
  • [22] Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
    Saavedra-Avendano, Biani
    Andrade-Romo, Zafiro
    Rodriguez, Maria I.
    Darney, Blair G.
    MATERNAL AND CHILD HEALTH JOURNAL, 2017, 21 (09) : 1724 - 1733
  • [23] Long-acting Reversible Contraception for Adolescents: Addressing the Provider Barrier
    Haider, Sadia
    Stoffel, Cynthia
    Cohen, Rebecca
    JOURNAL OF WOMENS HEALTH, 2013, 22 (10) : 888 - 888
  • [24] Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices
    Savage, Ashlyn H.
    Lindsay, Sarah F.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (05): : E130 - E139
  • [25] Adolescents' Intention to Use Long-Acting Reversible Contraception Postpartum
    Madorsky, Toni Z.
    Stritzel, Haley
    Sheeder, Jeanelle
    Maslowsky, Julie
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2024, 37 (05) : 510 - 515
  • [26] The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis
    Broecker, Jane
    Jurich, Joan
    Fuchs, Robin
    CONTRACEPTION, 2016, 93 (03) : 266 - 272
  • [27] Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
    Biani Saavedra-Avendano
    Zafiro Andrade-Romo
    Maria I. Rodriguez
    Blair G. Darney
    Maternal and Child Health Journal, 2017, 21 : 1724 - 1733
  • [28] LONG-ACTING REVERSIBLE CONTRACEPTION IN GENDER DIVERSE ADOLESCENTS AND YOUNG ADULTS: OUTCOMES FROM A MULTI-SITE COLLABORATIVE
    Abernathey, Liz
    Golub, Sarah
    Ahrens, Kym
    Ryan, Morgan E.
    Milliren, Carly
    Maslyanskaya, Sofya
    Borzutzky, Claudia
    DiVasta, Amy
    Pitts, Sarah
    JOURNAL OF ADOLESCENT HEALTH, 2023, 72 (03) : S72 - S72
  • [29] IMPACT OF TESTOSTERONE USE ON LONG-ACTING REVERSIBLE CONTRACEPTION (LARC) IN GENDER-DIVERSE ADOLESCENTS AND YOUNG ADULTS (AYA)
    Golub, S. A.
    Ryan, M.
    Milliren, C.
    Divasta, A.
    Pitts, S.
    CONTRACEPTION, 2023, 127 : 24 - 24
  • [30] Reversible Contraception Update: The Importance of Long-Acting Reversible Contraception
    Mestad, Renee E.
    Kenerson, Jessica
    Peipert, Jeffrey F.
    POSTGRADUATE MEDICINE, 2009, 121 (04) : 18 - 25